SAGE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.50%

Insider Buying (Last 12 Months): $37,280.00

Insider Selling (Last 12 Months): $0.00

Sage Therapeutics Insider Trading History Chart

Sage Therapeutics Share Price & Price History

^$10.99

▲ +0.52 (4.97%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

I’m giving you the name of this investment for free

From Porter & Company | Ad

This key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documentary I will provide you with all the details of this one-of-a-kind investment.

Let me explain in this new documentary video

Sage Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/9/2023	Elizabeth Barrett	Director	Buy	2,000	$18.64	$37,280.00	3,000
5/9/2023	Elizabeth Barrett	Director	Buy	1,000	$50.50	$50,500.00	1,000
2/10/2023	Jeffrey M Jonas	Director	Sell	11,643	$44.61	$519,394.23	121,981
5/5/2022	George Golumbeski	Director	Buy	8,000	$31.45	$251,600.00	8,000
8/5/2021	Barry E. Greene	CEO	Buy	23,640	$43.15	$1,020,066.00	32,440

The next companies to potentially benefit thanks to Nvidia are …

From Weiss Ratings | Ad

Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.

Click here to learn more.

SEC Filings (Institutional Ownership Changes) for Sage Therapeutics (NASDAQ:SAGE)

99.22% of Sage Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sage Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Bank of New York Mellon Corp	218,746	$2.38M	0.0%	+20.8%	0.363%
7/25/2024	Easterly Investment Partners LLC	136,602	$1.48M	0.1%	+24.6%	0.227%
7/25/2024	Baillie Gifford & Co.	63,333	$0.69M	0.0%	-21.6%	0.105%
7/20/2024	Nisa Investment Advisors LLC	6,230	$68K	0.0%	-67.4%	0.010%
7/20/2024	Hennion & Walsh Asset Management Inc.	41,837	$0.45M	0.0%	-37.2%	0.070%
7/19/2024	Values First Advisors Inc.	28,962	$0.32M	0.2%	+62.0%	0.048%
7/18/2024	Assenagon Asset Management S.A.	167,225	$1.82M	0.0%	+6.8%	0.278%
7/12/2024	SG Americas Securities LLC	16,278	$0.18M	0.0%	N/A	0.027%
7/9/2024	Harbor Capital Advisors Inc.	37,572	$0.41M	0.0%	+43.6%	0.062%
5/20/2024	Virtu Financial LLC	10,003	$0.19M	0.0%	N/A	0.017%
5/16/2024	California State Teachers Retirement System	53,904	$1.01M	0.0%	-4.9%	0.090%
5/16/2024	Jacobs Levy Equity Management Inc.	555,213	$10.41M	0.0%	-25.3%	0.923%
5/16/2024	Caxton Associates LP	55,745	$1.05M	0.1%	-53.5%	0.093%
5/15/2024	Baker BROS. Advisors LP	407,217	$7.63M	0.1%	N/A	0.677%
5/15/2024	Bellevue Group AG	4,465,544	$83.68M	1.3%	+27.1%	7.420%
5/15/2024	Price T Rowe Associates Inc. MD	811,934	$15.22M	0.0%	+69.8%	1.349%
5/15/2024	Lazard Asset Management LLC	6,825	$0.13M	0.0%	N/A	0.011%
5/13/2024	Seven Eight Capital LP	45,494	$0.85M	0.1%	+117.8%	0.076%
5/10/2024	Vanguard Group Inc.	5,751,373	$107.78M	0.0%	+8.1%	9.557%
5/9/2024	State Board of Administration of Florida Retirement System	16,644	$0.31M	0.0%	+9.8%	0.028%
5/8/2024	Entropy Technologies LP	19,243	$0.36M	0.0%	-47.4%	0.032%
5/8/2024	ProShare Advisors LLC	13,713	$0.26M	0.0%	+9.0%	0.023%
5/8/2024	Russell Investments Group Ltd.	41,392	$0.78M	0.0%	-31.2%	0.069%
5/8/2024	Inspire Investing LLC	19,234	$0.36M	0.0%	+9.4%	0.032%
5/3/2024	Easterly Investment Partners LLC	109,602	$2.05M	0.2%	-10.6%	0.182%
5/1/2024	BNP Paribas Financial Markets	197,089	$3.69M	0.0%	-41.4%	0.327%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	38,568	$0.72M	0.0%	+4.6%	0.064%
5/1/2024	Baillie Gifford & Co.	80,816	$1.51M	0.0%	-4.7%	0.134%
4/29/2024	China Universal Asset Management Co. Ltd.	11,554	$0.22M	0.0%	+66.6%	0.019%
4/26/2024	Pinnacle Associates Ltd.	285,917	$5.36M	0.1%	+69.6%	0.476%
4/24/2024	Assenagon Asset Management S.A.	156,593	$2.94M	0.0%	+1,058.4%	0.261%
4/18/2024	Allspring Global Investments Holdings LLC	48,632	$0.91M	0.0%	-12.5%	0.081%
4/17/2024	Hennion & Walsh Asset Management Inc.	66,567	$1.25M	0.1%	+8.2%	0.111%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	201,107	$4.36M	0.0%	+1,049.2%	0.335%
3/11/2024	Vanguard Group Inc.	5,319,360	$115.27M	0.0%	+2.1%	8.850%
3/5/2024	Fisher Asset Management LLC	431,925	$9.36M	0.0%	+8.1%	0.719%
3/5/2024	Wellington Management Group LLP	6,061,996	$131.36M	0.0%	-7.8%	10.085%
2/14/2024	Caxton Associates LP	119,781	$2.60M	0.1%	+76.1%	0.200%
2/14/2024	Pennant Investors LP	17,500	$0.38M	0.1%	N/A	0.029%
2/14/2024	Seven Eight Capital LP	20,884	$0.45M	0.1%	-51.0%	0.035%
2/14/2024	RTW Investments LP	5,197,019	$112.62M	1.8%	+0.9%	8.657%
2/14/2024	AdvisorShares Investments LLC	13,362	$0.29M	0.1%	-18.6%	0.022%
2/13/2024	Tower Research Capital LLC TRC	3,668	$79K	0.0%	-27.4%	0.006%
2/13/2024	Rafferty Asset Management LLC	306,914	$6.65M	0.0%	-25.5%	0.511%
2/12/2024	TD Asset Management Inc	53,662	$1.16M	0.0%	-33.5%	0.089%
2/9/2024	Primecap Management Co. CA	74,950	$1.62M	0.0%	-16.6%	0.125%
2/9/2024	Quest Partners LLC	12,022	$0.26M	0.1%	N/A	0.020%
2/9/2024	Trexquant Investment LP	103,097	$2.23M	0.1%	N/A	0.172%
2/9/2024	Dynamic Technology Lab Private Ltd	25,861	$0.56M	0.1%	N/A	0.043%
2/7/2024	Dimensional Fund Advisors LP	967,685	$20.97M	0.0%	-27.1%	1.612%
2/7/2024	Jump Financial LLC	21,418	$0.46M	0.0%	-75.7%	0.036%
2/7/2024	BNP Paribas Financial Markets	336,096	$7.28M	0.0%	-2.9%	0.560%
2/7/2024	Teacher Retirement System of Texas	12,469	$0.27M	0.0%	-18.4%	0.021%
2/7/2024	E Fund Management Co. Ltd.	16,482	$0.36M	0.0%	-22.1%	0.027%
2/6/2024	Charles Schwab Investment Management Inc.	413,905	$8.97M	0.0%	+1.2%	0.689%
2/6/2024	Amalgamated Bank	7,304	$0.16M	0.0%	-6.8%	0.012%
2/6/2024	Los Angeles Capital Management LLC	15,348	$0.33M	0.0%	N/A	0.026%
2/6/2024	Swiss National Bank	106,200	$2.30M	0.0%	-10.2%	0.177%
2/6/2024	Fisher Asset Management LLC	431,519	$9.35M	0.0%	+8.0%	0.719%
2/5/2024	Russell Investments Group Ltd.	60,140	$1.30M	0.0%	+158.0%	0.100%
2/1/2024	Handelsbanken Fonder AB	12,644	$0.27M	0.0%	+29.8%	0.021%
1/31/2024	abrdn plc	64,801	$1.40M	0.0%	N/A	0.108%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	12,256	$0.27M	0.0%	+31.9%	0.020%
1/29/2024	Clarius Group LLC	10,000	$0.22M	0.0%	-9.0%	0.017%
1/26/2024	Baillie Gifford & Co.	84,765	$1.84M	0.0%	-4.2%	0.141%
1/25/2024	Allspring Global Investments Holdings LLC	55,588	$1.21M	0.0%	-5.5%	0.093%
1/25/2024	Nisa Investment Advisors LLC	19,040	$0.41M	0.0%	+3,361.8%	0.032%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	36,875	$0.80M	0.0%	-6.8%	0.061%
1/24/2024	China Universal Asset Management Co. Ltd.	6,937	$0.15M	0.0%	+353.1%	0.012%
1/19/2024	Pinnacle Associates Ltd.	168,573	$3.65M	0.1%	-4.2%	0.281%
1/18/2024	Values First Advisors Inc.	16,980	$0.37M	0.2%	+59.8%	0.028%
1/17/2024	Assenagon Asset Management S.A.	13,518	$0.29M	0.0%	N/A	0.023%
1/8/2024	Harbor Capital Advisors Inc.	28,485	$0.62M	0.1%	-18.1%	0.047%
12/18/2023	Vanguard Group Inc.	5,208,002	$107.18M	0.0%	+3.5%	8.676%
12/13/2023	Teachers Retirement System of The State of Kentucky	21,020	$0.43M	0.0%	-72.4%	0.035%
12/7/2023	Hudson Bay Capital Management LP	275,000	$5.66M	0.0%	+1,733.3%	0.458%
12/6/2023	Citigroup Inc.	176,573	$3.63M	0.0%	+160.6%	0.294%
12/1/2023	Wellington Management Group LLP	6,572,260	$135.26M	0.0%	+3.3%	10.948%
11/24/2023	Deutsche Bank AG	1,028,301	$21.16M	0.0%	-0.6%	1.713%
11/17/2023	Jacobs Levy Equity Management Inc.	391,231	$8.05M	0.0%	N/A	0.652%
11/15/2023	RTW Investments LP	5,149,482	$105.98M	2.2%	N/A	8.587%
11/15/2023	Seven Eight Capital LP	42,632	$0.88M	0.1%	N/A	0.071%
11/14/2023	Palo Alto Investors LP	1,005,776	$20.70M	2.0%	+17.0%	1.677%
11/14/2023	Schonfeld Strategic Advisors LLC	129,419	$2.66M	0.0%	+521.5%	0.216%
11/14/2023	Caxton Associates LP	68,035	$1.40M	0.2%	N/A	0.113%
11/14/2023	Primecap Management Co. CA	89,850	$1.85M	0.0%	+41.3%	0.150%
11/14/2023	Profund Advisors LLC	68,755	$1.42M	0.1%	+167.7%	0.115%
11/13/2023	Algert Global LLC	56,690	$1.17M	0.1%	N/A	0.095%
11/13/2023	Federated Hermes Inc.	165,985	$3.42M	0.0%	N/A	0.277%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	17,500	$0.36M	0.0%	N/A	0.029%
11/13/2023	FMR LLC	7,696,055	$158.39M	0.0%	-12.4%	12.833%
11/13/2023	Rafferty Asset Management LLC	411,904	$8.48M	0.0%	+197.1%	0.687%
11/13/2023	Baillie Gifford & Co.	88,507	$1.82M	0.0%	-5.6%	0.148%
11/13/2023	E Fund Management Co. Ltd.	21,160	$0.44M	0.0%	+183.8%	0.035%
11/9/2023	Deutsche Bank AG	1,028,301	$21.16M	0.0%	-0.6%	1.717%
11/9/2023	Citigroup Inc.	176,573	$3.63M	0.0%	+160.6%	0.295%
11/9/2023	UBS Group AG	102,739	$2.11M	0.0%	+27.8%	0.172%
11/9/2023	Jupiter Asset Management Ltd.	49,793	$1.03M	0.0%	N/A	0.083%
11/8/2023	State of New Jersey Common Pension Fund D	126,693	$2.61M	0.0%	+161.8%	0.212%
11/8/2023	Charles Schwab Investment Management Inc.	408,987	$8.42M	0.0%	+4.6%	0.683%

Data available starting January 2016

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO, a CIV injection for the treatment of postpartum depression (PPD) in adults; and ZURZUVAE, a neuroactive steroid, a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors, for the treatment of postpartum depression. Its product pipeline also comprises SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases; and SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which is in Phase II clinical trial for the treatment of depression, Huntington's disease, Parkinson's diseases, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. The company has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $10.99

$10.49

$11.00

50 Day Range

MA: $11.30

$10.38

$13.08

52 Week Range

Now: $10.99

$9.73

$37.17

Volume

926,659 shs

Average Volume

1,113,026 shs

Market Capitalization

$661.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of Sage Therapeutics?: Sage Therapeutics' top insider investors include:
Jeffrey M Jonas (Director)
Elizabeth Barrett (Director)
Learn More about top insider investors at Sage Therapeutics.
Who are the major institutional investors of Sage Therapeutics?: Sage Therapeutics' top institutional shareholders include:
Bank of New York Mellon Corp — 0.36%
Assenagon Asset Management S.A. — 0.28%
Easterly Investment Partners LLC — 0.23%
Baillie Gifford & Co. — 0.11%
Hennion & Walsh Asset Management Inc. — 0.07%
Harbor Capital Advisors Inc. — 0.06%
Learn More about top institutional investors of Sage Therapeutics stock.
Which major investors are selling Sage Therapeutics stock?: In the previous quarter, SAGE stock was sold by these institutional investors:
Hennion & Walsh Asset Management Inc.
Baillie Gifford & Co.
Nisa Investment Advisors LLC
Which major investors are buying Sage Therapeutics stock?: Within the previous quarter, SAGE stock was bought by institutional investors including:
Bank of New York Mellon Corp
Easterly Investment Partners LLC
SG Americas Securities LLC
Harbor Capital Advisors Inc.
Values First Advisors Inc.
Assenagon Asset Management S.A.